Search

The article focuses on the potential implementation of the U.S.-style anti-fraud laws in the Australian pharmaceutical and health care industries. First, it explores the success of anti-fraud measures in the U.S. health care sector under the False Claims Act and the law's qui tam provisions. In contrast, the authors say that Australia allows treble damages recovery for fraud on the expense of the public and lacks large-scale anti-fraud claims actions. They call on the Australian government to create effective qui tam anti-fraud laws.

The goal of the qNMR Summit is to take stock of the status quo and the recent developments in qNMR research and applications in a timely and accurate manner. It provides a platform for both advanced and novice qNMR practitioners to receive a well-rounded update and discuss potential qNMR-related applications and collaborations. For over a decade, scientists from academia, industry, nonprofit institutions, and governmental bodies have focused on the standardization of qNMR methodology, as well as its metrological and pharmacopeial utility. This paper reviews key content of qNMR Summits 1.0 to 4.0 and puts into perspective the outcomes and available transcripts of the October 2019 Summit 5.0, with attendees from the United States, Canada, Japan, Korea, and several European countries. Summit presentations focused on qNMR methodology in the pharmaceutical industry, advanced quantitation algorithms, and promising developments.